NEWS AFFAIRS 7 : WHERE EVERY STORY HAS IT'S AFFAIR!
Last updated on August 21st, 2024 at 11:47 am
According to a Reuters report on August 18, close to 12% of Indian-tested spices did not meet the Food Safety and Standards Authority of India (FSSAI) quality and safety standards. This issue has arisen as several countries have taken action due to contamination risks associated with two popular Indian spice brands.
Read more: Top 5 Market Insights for the Week Ending August 16: Key Trends, IPOs, and Technical Analysis
Foreign investors sold ₹21,201 crore worth of Indian stocks Amid Global Uncertainties
Data from an RTI response reveals that out of 4,054 spice samples tested between May and early July, 474 samples failed to meet the required quality and safety parameters.
The United Kingdom has tightened its controls on spice imports from India. Meanwhile, New Zealand, the United States, and Australia are investigating the issues related to the Indian spice brands MDH and Everest.
Indian spice brands MDH and Everest, among the most popular in India and globally, have been in the spotlight due to recent quality concerns. Both brands have asserted that their products are safe for consumption. MDH and Everest, which sell their spices in Europe, Asia, and North America, were impacted when Hong Kong suspended the sale of some of their spice blends in April 2024 due to high pesticide levels.
Following this, the Food Safety and Standards Authority of India (FSSAI) conducted inspections and testing of mixed spice blends to address these concerns.
Disclaimer: This information is for educational purposes only and not investment advice. Always consult with a financial advisor before making any investment decisions.
Top 3 Price-Volume Breakout Stocks: Firstsource Solutions, Kitex Garments, and Pasupati Acrylon
India Reduces Windfall Profit Tax on Crude Oil to ₹2,100 Per Tonne
Orient Technologies IPO Day 1: Key Subscription Figures and Growth Insights
